Pipeline
Our lead product, MelCancerVac® has been tested in clinical trials for the treatment of two different types of cancer, colorectal cancer (CRC) and non-small-cell lung cancer (NSCLC).
CRC Clinical Trials
- Phase II at Gentofte Hospital, Denmark *Completed
- Phase II at the National Cancer Centre, Singapore *Completed
- Phase IIb at the National Cancer Centre, Singapore Starts Q3 2008
NSCLC Clinical Trials
- Phase II at Herlev Hospital, Denmark *Ongoing